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Optimization and standardization of the rat whole embryo culture (WEC) as an in vitro 
embryotoxicity test through the development of a new culture medium 
 
International guidelines of the Organisation of Economic Co-operation and Development 
(OECD) recommend the use of animal testing in reproductive toxicology to estimate the em-
bryotoxic potential of chemicals. According to the REACH (registration, evaluation and au-
thorisation of chemicals) Program of the European Union 30 000 of the “existing substances” 
must be investigated to determine their toxic potential within the next years. For this purpose, 
alternative methods to animal testing should be preferred, if they are validated according to 
the international validation guidelines and are accepted by regulatory agencies. Following the 
3R-principle of Russel and Burch [1] many alternative methods were developed over the past 
decades, the WEC being one of them. 
Today, the WEC is internationally validated to classify the embryotoxic potential of chemi-
cals or drugs. However, in order to be fully accepted by regulatory agencies it is necessary to 
further develop the WEC method to achieve general standardization. The recommended cul-
ture medium (100 % rat serum) has two disadvantages for the WEC embryotoxicity test. First, 
the rats have to be sacrificed to gain blood for the culture medium. Second, the charge vari-
ability of the rat serum biases the comparability of the obtained results. Therefore, not all 
given evaluation parameters of the embryos such as the growth could be incorporated into the 
prediction model during the validation study. At that time there was no alternative culture 
medium to rat serum which could have enabled a standardization of the culture system. There-
fore, it was the aim of this thesis to establish a culture medium which would be superior to rat 
serum. 
A direct comparison of the commonly used culture media of the WEC (human serum, hu-
man serum supplemented with 10 % rat serum and rat serum) and a bovine serum produced 
according to the protocol of Klug et al. [72] revealed that all heterologous sera have compara-
ble development-promoting potencies for rat embryos in culture. The use of commercially 
available bovine serum did not lead to sufficient results. A financially supported joint project 
was initiated to analyze this problem. In cooperation with a producer of culture media and 
animal sera the development-promoting potencies of commercial bovine sera (fetal bovine 
serum [FBS], donor bovine serum [DBS] and adult bovine serum [ABS] were investigated. 
As a first partial success, a combination of FBS and DBS supplemented with 10 % rat serum 
was identified which supported the development of rat embryos comparable to rat serum.  
Continuing investigations of possible influencing variables in the serum production led to a 
successful transfer of a modified protocol to produce bovine serum (suitable for the WEC 






A new subtype of industrially produced DBS, donor pregnant bovine serum (DPBS) was 
established. We achieved the highest development-promoting potency of all commercial DBS 
for rat embryos ever tested before. A second partial success was that DPBS supplemented 
with 10 % rat serum supported the development of rat embryos comparable to rat serum. 
Furthermore, we investigated the significance of the growth factors (insulin-like growth 
factor [IGF-1], epidermal growth factor [EGF] and vascular endothelial growth factor 
[VEGF]) as an alternative to the 10 % rat serum supplementation to improve the develop-
ment-promoting potencies of heterologous sera for rat embryos. RT-PCR analyses of the 
growth factor receptors revealed differences in there mRNA levels of IGF-1 and VEGF (Flt-
1) receptors in the whole embryos in comparison between in vivo and in vitro, but not for the 
EGF receptor. An increase of embryonic development could be caused by the supplementa-
tion of IGF-1 and even more profound by VEGF. These observations indicated that both 
growth factors are involved in the effect observable after a supplementation of 10 % rat serum 
to heterologous sera. 
To exclude the possibility of changed sensitivity and sensibility of the embryos to test sub-
stances caused by the new culture media, five reference substances were investigated. The 
observed effects using the new established culture media: 1. Serum mixture of ABS : FBS : 
RaS in the ratio 4.5 : 4.5 : 1 or 2. DPBS supplemented with 10 % rat serum were compared to 
the effects observed previously in WEC studies or in vivo. Both, the concentration-effect rela-
tionships and the specific adverse effects of penicillin G, ethanol, valproic acid, all-trans reti-
noic acid and 5-fluorouracil were comparable.  
The new culture media of the WEC provide the possibility to reduce the needed number of 
animals to produce the culture medium for the WEC by 90 % and to increase the batch size of 
the culture medium from 50-80 ml up to 20 000 to 50 000 ml. To ensure the availability of the 
new culture media they were incorporated into the commercially available product assortment 
of the cooperating company (Biochrom AG, Berlin). A German pharmaceutical company as 
well as the head of the WEC Validation Study were able to reproduce the development-
promoting potencies of these culture media for rat embryos. 
Two new culture media could be established for the WEC, enable the demanded wide-
spread standardization of the WEC, ensure the reproducibility of all evaluation parameters, 
are easily available world-wide, and above all, will dramatically reduce the sacrificing of ani-
mals for the WEC. 
 
